Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +1.75% | -6.07% | -88.68% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Apr. 02 | JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform | MT |
Evolution of the average Target Price on AN2 Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AN2 Therapeutics, Inc.
JMP Securities | |
Leerink Partners | |
Evercore ISI | |
Oppenheimer | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- ANTX Stock
- Consensus AN2 Therapeutics, Inc.